Filgotinib Market In Global
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, ... Read More
Oclacitinib is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.
This report contains market size and forecasts of Oclacitinib in global, including the following market information:
Global Oclacitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oclacitinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Oclacitinib companies in 2021 (%)
The global Oclacitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oclacitinib include Cayman Chemical, Toronto Research Chemicals, Taiclone, BioVision, Adooq Bioscience, APExBIO Technology, BOC Sciences, TargetMol and BioVision, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oclacitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oclacitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oclacitinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Oclacitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oclacitinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Oclacitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oclacitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oclacitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oclacitinib revenues share in global market, 2021 (%)
Key companies Oclacitinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Oclacitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
Toronto Research Chemicals
Taiclone
BioVision
Adooq Bioscience
APExBIO Technology
BOC Sciences
TargetMol
BioVision
MyBiosource
Biosynth Carbosynth
Clearsynth
Selleck Chemicals
MedKoo
CSNpharm
LifeSpan BioSciences
J&K Scientific
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, ... Read More
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment ... Read More
Fedratinib is a selective inhibitor of JAK2.Fedratinib has potential antineoplastic activity. Fed ... Read More
Lestaurtinib inhibits JAK2, FLT3, and TrkA with IC50s of 0.9, 3, and less than 25 nM, respectivel ... Read More